Rheumatoid Arthritis Resource Center
The Great Debate at ACR Convergence 2020 is: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA. No need to hang in suspense. In this resource center, you’ll get the pros and cons, and highlights from other important sessions on rheumatoid arthritis (RA). Plus, you can explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of RA.
VIEW
A Closer Look at Antibodies in RA: How Anti-Citrullinated Protein Antibodies, Anti-Modified Protein Autoantibodies & Rheumatoid Factor Activity Overlap
Coronary Microvascular Dysfunction May Predict Heart Disease in Rheumatoid Arthritis
Study Probes Utility of Neutrophil Biomarkers in Rheumatoid Arthritis
The Case for Integrated Musculoskeletal Care Teams
Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis
Resetting Immune Tolerance to Prevent RA
Experts Discuss Unique Challenges Posed by Difficult-to-Treat RA
Dr. Blair Solow’s Picks for the Top RA Research Presented at ACR Convergence 2020
ACR Introduces Draft Guideline for RA Management
- 1
- 2
- 3
- …
- 62
- Next Page »